Non-ischemic cardiomyopathy in the elderly: A shocking conundrum

[1]  S. Saba,et al.  Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients , 2018, Indian pacing and electrophysiology journal.

[2]  Y. On.  Defibrillator Implantation in Patients with Nonischemic Systolic HeartFailure. , 2017 .

[3]  Hans Eiskjær,et al.  Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.

[4]  K. Reinier,et al.  Electrocardiographic Markers and the Left Ventricular Ejection Fraction have Cumulative Effects on Risk of Sudden Cardiac Death. , 2015, JACC. Clinical electrophysiology.

[5]  S. Barra,et al.  Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  J. Healey,et al.  Survival After Implantable Cardioverter-Defibrillator Implantation in the Elderly , 2013, Circulation.

[7]  G. Stukenborg,et al.  Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. , 2012, Journal of the American College of Cardiology.

[8]  P. Heidenreich,et al.  Influence of Age on Perioperative Complications Among Patients Undergoing Implantable Cardioverter-Defibrillators for Primary Prevention in the United States , 2011, Circulation. Cardiovascular quality and outcomes.

[9]  J. Curtis,et al.  Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation , 2011, Circulation.

[10]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[11]  S. Shkurovich,et al.  Implantable cardioverter-defibrillator prescription in the elderly. , 2009, Heart rhythm.

[12]  Claudia Stöllberger,et al.  Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[13]  M. Turakhia,et al.  Impact of advanced age on survival in patients with implantable cardioverter defibrillators. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[14]  E. Prystowsky,et al.  Complications Associated with Generator Replacement in Response to Device Advisories , 2008, Journal of cardiovascular electrophysiology.

[15]  J. Healey,et al.  Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. , 2007, European heart journal.

[16]  W. Grimm,et al.  Outcomes of Elderly Recipients of Implantable Cardioverter Defibrillators , 2007, Pacing and clinical electrophysiology : PACE.

[17]  D. Cohen,et al.  The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. , 2006, Journal of the American College of Cardiology.

[18]  Alvin I Mushlin,et al.  The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. , 2006, Journal of the American College of Cardiology.

[19]  A. Krahn,et al.  Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. , 2006, JAMA.

[20]  Douglas K Owens,et al.  Cost-effectiveness of implantable cardioverter-defibrillators. , 2005, The New England journal of medicine.

[21]  Eric Fain,et al.  Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. , 2004, The New England journal of medicine.

[22]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[23]  Hugh Calkins,et al.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.

[24]  S. Connolly,et al.  Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. , 2004, American heart journal.

[25]  D. Carroll,et al.  The effects of age on quality of life in implantable cardioverter defibrillator recipients. , 2004, Journal of clinical nursing.

[26]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[27]  R. Cappato,et al.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). , 2000, Circulation.

[28]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[29]  A Laupacis,et al.  What is the quality of life for survivors of cardiac arrest? A prospective study. , 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[30]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[31]  P. Voisine,et al.  Transcatheter Mitral-Valve Repair in Patients with Heart Failure. , 2019, The New England journal of medicine.

[32]  L. Jordaens,et al.  Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[33]  Jeroen J. Bax,et al.  Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[34]  N Engl,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.